The findings presented in this study emphasize the influence of peripheral blood in the advancement of tau aggregation within the brain, being crucial for AD and other tauopathies, as peripheral tau aggregates represent a promising target for therapeutic interventions aimed at reducing tau burden in the CNS and mitigating the progression of tau-related neurodegenerative diseases. Here, MAPT is linked to tauopathy.